PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34415333-7	2021	Ex vivo treatment of mesenteric arteries with an AMPK agonist (A769662) or a PPARdelta agonist (GW1516) improved the impaired EDR in DMO and reversed the tunicamycin-induced ER stress, ROS production, and EDR impairment in mesenteric arteries from CMO.	Tunicamycin	154-165	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	49-53